curvetl curvetr
Contact Us image
header
curvebl curvebr
curvetl curvetr
Member login
Side Menu

headergif

Questionnaire

headergif

The results of the TEMPOtest-QC questionnaire are available in a free publication published in the journal “Patient Preference and Adherence” in June 2103.

The journal reference is:

"Perceptions of point-of-care infectious disease testing among European medical personnel, point-of-care test kit manufacturers, and the general public."
Authors: Kaman WE, Andrinopoulou ER, Hays JP
June 2013 Volume 2013:7 Pages 559 - 577


To access the publication please go to

http://www.dovepress.com/articles.php?article_id=13397


Some of the main results are also presented below.

Background:: The proper development and implementation of point-of-care (POC) diagnostics requires knowledge of the perceived requirements and barriers to their implementation. To determine the current requirements and perceived barriers to the introduction of POC diagnostics in the field of medical microbiology (MM)-POC a prospective online survey (TEMPOtest-QC) was established.


Methods and results: The TEMPOtest-QC survey was online between February 2011 and July 2012 and targeted the medical community, POC test diagnostic manufacturers, general practitioners, and the general public. In total, 293 individuals responded to the survey, including 91 (31%) medical microbiologists, 39 (13%) nonmedical microbiologists, 25 (9%) employees of POC test manufacturers, and 138 (47%) members of the general public. Responses were received from 18 different European countries, with the largest percentage of these living in The Netherlands (52%). The majority (.50%) of medical specialists regarded the development of MM-POC for blood culture and hospital acquired infections as “absolutely necessary”, but were much less favorable towards their use in the home environment. Significant differences in perceptions between medical specialists and the general public included the: (1) Effect on quality of patient care; (2) Ability to better monitor patients; (3) Home testing and the doctor-patient relationship; and (4) MM-POC interpretation. Only 34.7% of the general public is willing to pay more than €10 ($13) for a single MM-POC test, with 85.5% preferring to purchase their MM-POC test from a pharmacy.


Conclusion: The requirements for the proper implementation of MM-POC were found to be generally similar between medical specialists and POC test kit manufacturers. The general public was much more favorable with respect to a perceived improvement in the quality of healthcare that these tests would bring to the hospital and home environment.



Figure 1. Mean responses of medical specialists regarding the current perceived necessity for MM-POC in relationship to type of disease. The majority regarded the development of MM-POC against both hospital acquired and blood culture infections as “Absolutely Necessary”.



Figure 2. Opinions of target groups regarding the use of infectious disease (bacterial/fungal) POC devices in different environments. Medical specialists (hospital medical microbiologists and nonmedical microbiology specialists) (M), POCT manufacturers (P), and the general public (G) regarding the applicability of MM-POC in hospital wards, at the general practitioner or at the patient’s home. Abbreviations: G, general practitioners; M, medical specialists; P, POCT manufacturers; POCT, point-of-care test; MM-POC, medical microbiological point-of-care tests.


Table 1. Opinions of target groups regarding the most relevant specifications for bacterial or fungal point-of-care diagnostics.


Table 2. Opinions of target groups regarding the effect of point-of-care testing on the quality of health care



Table 3. Perceived effect of the introduction of bacterial or fungal point-of-care testing technologies according to the general public



Finally:

Thank you very much for your participation and interest in TEMPOtest-QC !


7thframeworklogo The TEMPOtest-QC project has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement no 241742 EUFlag
curvebl curvebr